Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 22 No 4 April/May 2017

Book of the Month

Cover of Whistleblowing: Law and Practice

Whistleblowing: Law and Practice

Price: £175.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


UK Public Holiday May 2017

Wildy's will be closed on Monday 29th May and will re-open on Tuesday 30th May.

Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.

As usual Credit Cards will not be charged until the order is processed and ready to despatch.

Any non-UK eBook orders placed after 5pm on the Friday 26th May will not be processed until Tuesday 30th May. UK eBook orders will be processed as normal.

Hide this message

Supplementary Protection Certificates

Image not available lge

ISBN13: 9781781952405
To be Published: May 2017
Publisher: Edward Elgar Publishing Limited
Country of Publication: UK
Format: Hardback
Price: £125.00

This detailed book from a leading patent practitioner provides a systematic, dedicated practical analysis of Supplementary Protection Certificates. In particular it provides close examination of the Medicinal Products SPC Regulation (which came into force 20 years ago and was aimed at extending effective patent term for pharmaceuticals) and the Plant Protection Products SPC Regulation which followed it several years later. The interpretation of these measures, marrying as they do concepts drawn from the disparate areas of patent and regulatory law, has proved to be a source of enormous controversy, resulting most recently in what has in effect been their judicial rewriting along teleological principles. Trevor Cook presents a measured and much-needed analysis of these instruments and the case law that has been used to interpret them. The book will be an essential resource for patent practitioners, including patent attorneys, patent lawyers in private practice, and counsel at pharmaceutical companies. It will also appeal to IP scholars as an in-depth treatment of these measures.